Myocardial perfusion scintigraphy and cost effectiveness of diagnosis and management of coronary heart disease

Heart

Volumn 90, Issue SUPPL. 5, 2004, Pages

  Underwood, S R ^a   Shaw, L J ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Atlanta Cardiovasc Res Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; BAYES THEOREM; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; HEALTH CARE COST; HEALTH ECONOMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; NON INVASIVE MEASUREMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; THORAX PAIN; UNITED KINGDOM; UNITED STATES;

CORONARY DISEASE; COST-BENEFIT ANALYSIS; HUMANS; RADIONUCLIDE ANGIOGRAPHY;

EID: 3242885918     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.019133     Document Type: Article

References (19)

1. Shaw LJ, Eisenstein EL, Hachamovitch R, et al. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: part II. J Nucl Cardiol 1997;4:52-60.
2. Underwood SR, Godman B, Salyani S, et al. Economics of myocardial perfusion imaging in Europe - the EMPIRE study. Eur Heart J 1999;20:157-66.
3. Mark DB, Shaw LJ, Lauer MS, et al. Is atherosclerotic imaging cost effective? J Am Coll Cardiol 2003;41:1906-17.
4. Kuntz KM. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130:709-18.
5. Maddahi J, Ghambir SS. Cost-effective selection of patients for coronary angiography. J Nucl Cardiol 1997;4:S141-51.
6. Shaw LJ, Hachamovitch R, Eisenstein E, et al. Cost implications for implementing a selective preoperative risk screening approach for peripheral vascular surgery patients. Am J Managed Care 1997;3:1817-27.
7. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999;130:719-28.
8. Goldman L, Garber AM, Grover SA, et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for CAD events. Task force 6: cost effectiveness of assessment and management of risk factors, J Am Coll Cardiol 1996;27:1020-30.
9. Patterson RE, Eng C, Horowitz SF, et al. Bayesian comparison of cost-effectiveness of different clinical approaches to coronary artery disease. J Am Coll Cardiol 1984;4:278-89.
10. Wong JB, Sonnenberg FA, Salem DN, et al. Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 1990;113:852-71.
11. Goldman L, Weinstein MC, Goldman PA, et al. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991;265:1145-51.
12. Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of noninvasive diagnosis (END) multicenter study group. J Am Coll Cardiol 1999;33:661-9.
13. Shaw LJ, Marwick TH, Sawada S, et al. Prognostic value and cost effectiveness of exercise-induced ischemia by echocardiography versus SPECT imaging for the evaluation of patients with stable chest pain [abstract]. Circulation 2002;106(suppl II):II-610.
14. Lee DS, Jang MJ, Cheon GJ, et al. Comparison of the cost-effectiveness of stress myocardial perfusion SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results. J Nucl Cardiol 2002;9:515-22.
15. Bateman TM. Nuclear cardiology in private practice. J Nucl Cardiol 1997;4:S184-8.
16. Wong Y, Rodwell A, Dawkins S, et al. Sex differences in investigation results and treatment in subjects referred for investigation of chest pain. Heart 2001;85:149-52.
17. Underwood SR. Cost-effective investigation of chest pain (electronic correspondence). Heart 2001 http://heart.bmjjournals.com/cgi/eletters/ 85/2/149.
18. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. J Am Coll Cardiol 1999;33:1756-824.
19. Shaw LJ, Hachamovitch R, Papatheofanis FJ. Outcomes and technology assessment in nuclear medicine. Reston, Virginia: Society of Nuclear Medicine Press, 1999.